Everest Pharma Launches RUXOTOR Tablets, a Generic Version of FDA-Approved JAKAFI (Ruxolitinib Tablets)

Jakafi (Ruxolitinib): The First FDA-Approved Treatment for Polycythemia Vera

A Decade of Ruxolitinib in Myelofibrosis: Long-Term Safety and Clinical Insights